Price Alert

TuHURA Biosciences Inc. (HURA)

NASDAQ: HURA · Real-Time Price · USD

2.60

-0.01 (-0.38%)

At close: Oct 03, 2025, 3:59 PM

2.64

1.54%

After-hours: Oct 03, 2025, 06:29 PM EDT

TuHURA Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	8.51M	12.66M	3.02M	4.91M	4.46M	658K	216K	1.53M	9.82M	4.87M	7.08M	11.78M	8.84M	14.06M	19.34M	10.54M	15.72M
Short-Term Investments	n/a	5.99M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	33.77K	n/a	n/a	33.77K	n/a	n/a	n/a	n/a	n/a	4.3M	2.6M	2.6M	2.6M	2.1M	1.6M	2.1M
Receivables	3M	222.7K	258K	n/a	334.44K	103K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	7K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.03M	316.35K	n/a	619K	500.97K	425K	567K	1.74M	290.87K	4.3M	1.07M	1.48M	1.25M	934K	769K	1.26M	863K
Total Current Assets	12.54M	19.61M	3.48M	5.53M	5.3M	1.19M	783K	3.27M	10.11M	9.18M	8.16M	13.26M	10.09M	15M	20.11M	11.79M	16.59M
Property-Plant & Equipment	144.17K	322.53K	657K	674K	455.04K	699K	694K	709K	329.89K	739K	754K	90K	105K	120K	135K	150K	165K
Goodwill & Intangibles	21.82M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	21.96M	356.29K	657K	674K	488.81K	699K	694K	709K	329.89K	739K	5.05M	2.69M	2.71M	2.72M	2.23M	1.75M	2.27M
Total Assets	34.62M	19.97M	4.14M	6.2M	5.79M	1.89M	1.48M	3.98M	10.44M	9.92M	13.21M	15.95M	12.8M	17.72M	22.34M	13.54M	18.85M
Account Payables	n/a	3.15M	1.28M	2.21M	1.64M	1.72M	3M	2.78M	291.13K	2.69M	2.94M	3.27M	2.78M	2.9M	2.51M	2.22M	1.65M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	434K	159.84K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	503K
Other Current Liabilities	2.52M	855.7K	3.15M	52K	2.06M	148K	338K	298K	1.16M	548K	573K	721K	458K	543K	491K	561K	385K
Total Current Liabilities	15.17M	5.33M	5.43M	2.26M	4.84M	1.87M	3.34M	3.08M	3.28M	3.24M	3.52M	3.99M	3.24M	3.44M	3M	2.78M	2.53M
Long-Term Debt	n/a	n/a	n/a	n/a	6.85M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	24.45M	186K	n/a	179K	167K	166K	n/a	80K	76K	163K	172K	178K	179K	182K	202K
Total Long-Term Liabilities	n/a	42.7K	24.45M	186K	7.01M	179K	167K	166K	n/a	80K	76K	163K	172K	178K	179K	182K	202K
Total Liabilities	15.17M	5.37M	2.44M	2.44M	11.85M	2.05M	3.5M	3.25M	3.28M	3.32M	3.59M	4.15M	3.41M	3.62M	3.18M	2.96M	2.73M
Total Debt	558.97K	202.54K	n/a	n/a	7.16M	n/a	n/a	n/a	110.02K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	503K
Book Value	19.45M	14.59M	1.7M	3.76M	-6.07M	-164K	-2.03M	731K	7.16M	6.6M	9.62M	11.79M	9.39M	14.1M	19.16M	10.58M	16.12M
Book Value Per Share	0.44	34.48	4.03	31.60	-14.43	-1.32	-23.52	15.12	151.43	140.56	229.93	314.98	334.34	508.55	978.25	565.59	963.59
Common Stock	49.91K	42.32K	7.64K	55K	6.81K	10K	2K	2K	6.56K	2K	81K	66K	49K	49K	48K	33K	32K
Retained Earnings	-127.32M	-111.12M	-162.05M	-159.88M	-93.32M	-155.54M	-154.51M	-151.38M	-77.87M	-144.77M	-141.32M	-136.36M	-130.91M	-125.55M	-119.66M	-111.22M	-104.49M
Comprehensive Income	n/a	n/a	21K	21K	n/a	21K	21K	21K	21K	21K	21K	21K	21K	21K	21K	21K	21K
Shareholders Equity	19.45M	14.59M	1.7M	3.76M	-6.07M	-164K	-2.03M	731K	7.16M	6.6M	9.62M	11.79M	9.39M	14.1M	19.16M	10.58M	16.12M
Total Investments	n/a	5.99M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a